Irvine, CA, United States of America

Sherry M Haynes

This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2002.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 12(Granted Patents)


Company Filing History:

goldMedal1 out of 834,411 
Other
 patents

Years Active: 2002

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Sherry M Haynes: Innovator in Liposome Technology

Introduction

Sherry M Haynes is a notable inventor based in Irvine, CA (US). He has made significant contributions to the field of liposome technology, particularly in the development of delivery vehicles for intracellular and intranuclear applications. His innovative work has the potential to enhance the effectiveness of drug delivery systems.

Latest Patents

Sherry M Haynes holds 1 patent for his invention titled "Liposome fusion and delivery vehicle." This patent describes liposome complexes and their individual components designed for the intracellular and/or intranuclear delivery of substances. The invention outlines methods of using these liposome complexes, which include a non-cationic lipid, a fusogenic peptide, and a substance intended for delivery to the cell and/or nucleus. Notably, the fusogenic peptide in some complexes does not contain multiple positive charges at neutral pH and above, utilizing two additional components for assembling the liposome complex with DNA.

Career Highlights

Throughout his career, Sherry M Haynes has focused on advancing liposome technology. His work has been instrumental in developing methods that improve the delivery of therapeutic agents, which can lead to more effective treatments in various medical fields.

Collaborations

Sherry has collaborated with esteemed colleagues such as Kenneth J Longmuir and Alan J Waring. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

Sherry M Haynes is a pioneering inventor whose work in liposome technology has the potential to revolutionize drug delivery systems. His innovative approaches and collaborations continue to influence the field positively.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…